120 related articles for article (PubMed ID: 15367280)
1. Mycophenolate mofetil and reduced doses of cyclosporine in pediatric liver transplantation with chronic renal dysfunction: changes in the immune responses.
Ferraris JR; Duca P; Prigoshin N; Tambutti ML; Boldrini G; Cardoni RL; D'Agostino D
Pediatr Transplant; 2004 Oct; 8(5):454-9. PubMed ID: 15367280
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction.
Cantarovich M; Tzimas GN; Barkun J; Deschênes M; Alpert E; Tchervenkov J
Transplantation; 2003 Jul; 76(1):98-102. PubMed ID: 12865793
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center.
Tannuri U; Gibelli NE; Maksoud-Filho JG; Santos MM; Pinho-Apezzato ML; Velhote MC; Ayoub AA; Silva MM; Maksoud JG
Pediatr Transplant; 2007 Feb; 11(1):82-6. PubMed ID: 17239128
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
[TBL] [Abstract][Full Text] [Related]
5. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
[TBL] [Abstract][Full Text] [Related]
6. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil in liver transplantation.
McDiarmid SV
Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation.
Créput C; Blandin F; Deroure B; Roche B; Saliba F; Charpentier B; Samuel D; Durrbach A
Liver Transpl; 2007 Jul; 13(7):1004-10. PubMed ID: 17600361
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation.
Evans HM; McKiernan PJ; Kelly DA
Transplantation; 2005 Jun; 79(11):1575-80. PubMed ID: 15940048
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.
Benz K; Plank C; Griebel M; Montoya C; Dötsch J; Klare B
Pediatr Transplant; 2006 May; 10(3):331-6. PubMed ID: 16677357
[TBL] [Abstract][Full Text] [Related]
12. Clinical evolution in the first 3 months of patients after liver transplantation in maintenance phase converted from mycophenolate mofetil to mycophenolate sodium due to gastrointestinal complications.
Miras M; Carballo F; Egea J; Martínez C; Alvarez-López MR; Sánchez-Bueno F; Parrilla P
Transplant Proc; 2007 Sep; 39(7):2314-7. PubMed ID: 17889175
[TBL] [Abstract][Full Text] [Related]
13. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.
Ferraris JR; Ghezzi LF; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
Pediatr Transplant; 2005 Apr; 9(2):178-82. PubMed ID: 15787789
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
[TBL] [Abstract][Full Text] [Related]
15. Renal function outcome in pediatric liver transplant recipients.
Mention K; Lahoche-Manucci A; Bonnevalle M; Pruvot FR; Declerck N; Foulard M; Gottrand F
Pediatr Transplant; 2005 Apr; 9(2):201-7. PubMed ID: 15787794
[TBL] [Abstract][Full Text] [Related]
16. Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function.
Hueso M; Bover J; Serón D; Gil-Vernet S; Sabaté I; Fulladosa X; Ramos R; Coll O; Alsina J; Grinyó JM
Transplantation; 1998 Dec; 66(12):1727-31. PubMed ID: 9884267
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
Gonzalez Molina M; Seron D; Garcia del Moral R; Carrera M; Sola E; Jesus Alferez M; Gomez Ullate P; Capdevila L; Gentil MA
Transplantation; 2004 Jan; 77(2):215-20. PubMed ID: 14742984
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Comparison of Mycophenolate Mofetil with Low-Exposure Cyclosporine Versus Standard Cyclosporine Therapy in De Novo Liver Transplant Patients.
Senft JD; Gotthardt DN; Frischbier L; Bruns H; Schemmer P
Ann Transplant; 2015 Sep; 20():539-43. PubMed ID: 26364728
[TBL] [Abstract][Full Text] [Related]
19. Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.
Baryalei M; Zenker D; Pieske B; Tondo K; Dalichau H; Aleksic I
Transplant Proc; 2003 Jun; 35(4):1539-42. PubMed ID: 12826215
[TBL] [Abstract][Full Text] [Related]
20. [Mycophenolate mofetil-based calcineurin inhibitor reduced immunosuppressive protocol for the improvement of renal dysfunction after liver transplantation].
Lai W; Lu SC; Wang ML; Zhang J; Wu JS; Dai J; Zeng DB; Xia RP; Li N
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1529-32. PubMed ID: 19953878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]